© Reuters. FILE PHOTO: A Walgreens retailer is seen in Chicago, Illinois, U.S. February 11, 2021. REUTERS/Eileen T. Meslar
(Reuters) -Walgreens Boots Alliance Inc’s fourth-quarter results beat estimates on larger U.S. and UK pharmacy retailer gross sales as a result of easing of pandemic-related restrictions and other people getting COVID-19 vaccines at its shops.
The firm has administered greater than 40 million COVID-19 vaccines and over 16 million exams to this point, it mentioned.
Same-store gross sales at its U.S. pharmacies rose 8.8% within the fourth quarter, which included a 485 foundation level increase from COVID-19 vaccinations, the corporate mentioned. Walgreens crammed 313 million prescriptions through the quarter.
Shares within the Deerfield, Illinois-based firm, one of many largest U.S. pharmacies, rose 1.6% to $48 premarket.
Net earnings attributable to the corporate was $627 million, or 72 cents per share, for the quarter ended Aug. 31, in contrast with a revenue of $373 million, or 43 cents per share, a 12 months earlier.
Excluding objects, the corporate earned $1.17 per share, in contrast with Refinitiv IBES estimates of $1.02 per share.
Revenue rose to $34.26 billion from $30.37 billion, whereas analysts on common had estimated $33.30 billion.
Fusion Media or anybody concerned with Fusion Media won’t settle for any legal responsibility for loss or injury because of reliance on the data together with information, quotes, charts and purchase/promote indicators contained inside this web site. Please be totally knowledgeable concerning the dangers and prices related to buying and selling the monetary markets, it is among the riskiest funding kinds attainable.